Cargando…

FAM225B Is a Prognostic lncRNA for Patients with Recurrent Glioblastoma

OBJECTIVE: The overall survival of patients with recurrent glioblastoma (rGBM) is quite different, so clinical outcome prediction is necessary to guide personalized clinical treatment for patients with rGBM. The expression level of lncRNA FAM225B was analyzed to determine its prognostic value in rGB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Junsheng, Zhang, Qian, Ge, Peicong, Zeng, Chaofan, Lin, Fa, Wang, Wen, Zhao, Jizong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704151/ https://www.ncbi.nlm.nih.gov/pubmed/33299501 http://dx.doi.org/10.1155/2020/8888085

Ejemplares similares

Prognostic Significance of Homocysteine Level on Neurological Outcome in Brain Arteriovenous Malformations
por: Lin, Fa, et al.
Publicado: (2020)

LncRNA FAM225B Regulates PDIA4-Mediated Ovarian Cancer Cell Invasion and Migration via Modulating Transcription Factor DDX17
por: Yao, Chanjiao, et al.
Publicado: (2023)

Homocysteine Level and Risk of Hemorrhage in Brain Arteriovenous Malformations
por: Zeng, Chaofan, et al.
Publicado: (2021)

LncRNA-FAM66C Was Identified as a Key Regulator for Modulating Tumor Microenvironment and Hypoxia-Related Pathways in Glioblastoma
por: Liu, Dan, et al.
Publicado: (2022)

Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma
por: Li, Mingdong, et al.
Publicado: (2019)

Liver-specific lncRNA FAM99A may be a tumor suppressor and promising prognostic biomarker in hepatocellular carcinoma
por: Mo, Meile, et al.
Publicado: (2022)

The clinical prognostic value of lncRNA FAM83H-AS1 in cancer patients: a meta-analysis
por: Yang, Qin, et al.
Publicado: (2020)

Exosomal lncRNA FAM225A accelerates esophageal squamous cell carcinoma progression and angiogenesis via sponging miR‐206 to upregulate NETO2 and FOXP1 expression
por: Zhang, Chunyu, et al.
Publicado: (2020)

Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer
por: Yang, Fan, et al.
Publicado: (2016)

Identification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastoma
por: Li, Yongsheng, et al.
Publicado: (2016)

Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma
por: Yu, Wanli, et al.
Publicado: (2021)

LncRNA FAM83A‐AS1 promotes lung adenocarcinoma progression by enhancing the pre‐mRNA stability of FAM83A
por: Wang, Wenyi, et al.
Publicado: (2021)

LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas
por: Wang, Wen, et al.
Publicado: (2016)

Construction of lncRNA-mediated ceRNA network to reveal clinically relevant lncRNA biomarkers in glioblastomas
por: Zan, Xiang-Yang, et al.
Publicado: (2019)

A Five Immune-Related lncRNA Signature as a Prognostic Target for Glioblastoma
por: Li, Xiaomeng, et al.
Publicado: (2021)

Identification of an epithelial-mesenchymal transition-related lncRNA prognostic signature for patients with glioblastoma
por: Yang, XinJie, et al.
Publicado: (2021)

LncRNA GAS8‐AS1 downregulates lncRNA NEAT1 to inhibit glioblastoma cell proliferation
por: Wu, Xiaoming, et al.
Publicado: (2021)

Association between methionine sulfoxide and risk of moyamoya disease
por: Li, Junsheng, et al.
Publicado: (2023)

Integrated analysis of the association between methionine cycle and risk of moyamoya disease
por: Li, Junsheng, et al.
Publicado: (2023)

Construction of m6A-Related lncRNA Prognostic Signature Model and Immunomodulatory Effect in Glioblastoma Multiforme
por: Xie, Pan, et al.
Publicado: (2022)

Prediction of the Outcome for Patients with Glioblastoma with lncRNA Expression Profiles
por: Liu, Qinglin, et al.
Publicado: (2019)

LncRNA HLA-F-AS1 Enhances the Migration, Invasion and Apoptosis of Glioblastoma Cells by Targeting lncRNA MEG3
por: Wang, Yanhua, et al.
Publicado: (2021)

LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis
por: Han, Chunyong, et al.
Publicado: (2020)

A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures
por: Jin, Lipeng, et al.
Publicado: (2020)

Six-lncRNA Immune Prognostic Signature for Cervical Cancer
por: Chen, Qian, et al.
Publicado: (2020)

LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to protect β-catenin from degradation
por: Zhou, Min, et al.
Publicado: (2022)

Decreased Expression of a Novel lncRNA FAM181A-AS1 is Associated with Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma
por: Liang, Weiquan, et al.
Publicado: (2022)

Novel lncRNA lncFAM200B: Molecular Characteristics and Effects of Genetic Variants on Promoter Activity and Cattle Body Measurement Traits
por: Zhang, Sihuan, et al.
Publicado: (2019)

Genetic landscape of long noncoding RNA (lncRNAs) in glioblastoma: identification of complex lncRNA regulatory networks and clinically relevant lncRNAs in glioblastoma
por: Paul, Yashna, et al.
Publicado: (2018)

LncRNA AWPPH overexpression predicts the recurrence of periodontitis
por: Wang, Xiaofang, et al.
Publicado: (2019)

Integrated Analysis of LncRNA-mRNA Co-Expression Profiles in Patients with Moyamoya Disease
por: Wang, Wen, et al.
Publicado: (2017)

LncRNA FAM66C inhibits pancreatic cancer progression by sponging miR-574-3p
por: Zhu, Jiangang, et al.
Publicado: (2020)

Prognostic pyroptosis-related lncRNA signature predicts the efficacy of immunotherapy in hepatocellular carcinoma
por: Cheng, Zina, et al.
Publicado: (2022)

A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme
por: Gao, Ming, et al.
Publicado: (2021)

Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma
por: Xing, Zhe, et al.
Publicado: (2022)

LncRNA PTCSC3 Alleviates the Postoperative Distant Recurrence of Gastric Cancer by Suppression of lncRNA HOXA11-AS
por: Xu, Jiapeng, et al.
Publicado: (2020)

Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma
por: Fu, Yi, et al.
Publicado: (2021)

Analyzing the lncRNA, miRNA, and mRNA-associated ceRNA networks to reveal potential prognostic biomarkers for glioblastoma multiforme
por: Zhu, Xiaolong, et al.
Publicado: (2020)

Corrigendum: Novel lncRNA lncFAM200B: Molecular Characteristics and Effects of Genetic Variants on Promoter Activity and Cattle Body Measurement Traits
por: Zhang, Sihuan, et al.
Publicado: (2021)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6fbsqnpvk0rcskb8o7d3h1s5d8